Proceedings of the National Academy of Sciences · 2012 · 259 citations · 34 references
Life SciencesNeurosciencePsychiatryCognitive NeuroscienceNeuropharmacologyNeuropsychiatryGlutamatergic SignalingNeurocognitive FunctionNeurotransmissionSchizophrenia Spectrum DisordersSynaptic TransmissionWorking MemoryCognitive Impairment In SchizophreniaGlutamatergic Circuit FunctionNeurocognitive DeficitsNeuronal Circuit FunctionNmda Receptor AntagonismNmda Receptor AntagonistsNmda Receptor FunctionNmda Receptors
Glutamatergic neurotransmission mediated by N-methyl-d-aspartate (NMDA) receptors is vital for the cortical computations underlying cognition and might be disrupted in severe neuropsychiatric illnesses such as schizophrenia. Studies on this topic have been limited to processes in local circuits; however, cognition involves large-scale brain systems with multiple interacting regions. A prominent feature of the human brain's global architecture is the anticorrelation of default-mode vs. task-positive systems. Here, we show that administration of an NMDA glutamate receptor antagonist, ketamine, disrupted the reciprocal relationship between these systems in terms of task-dependent activation and connectivity during performance of delayed working memory. Furthermore, the degree of this disruption predicted task performance and transiently evoked symptoms characteristic of schizophrenia. We offer a parsimonious hypothesis for this disruption via biophysically realistic computational modeling, namely cortical disinhibition. Together, the present findings establish links between glutamate's role in the organization of large-scale anticorrelated neural systems, cognition, and symptoms associated with schizophrenia in humans.
34
Toward discovery science of human brain function
Bharat B. Biswal, Maarten Mennes, Xi‐Nian Zuo et al. · Proceedings of the National Academy of Sciences · 2010 · 3.1K citations · Full text